• Unaudited total revenue of US$0.77m, up 5.8% on Q4 CY24
• Enlitic named as a foundational collaborator for GE HealthCare's Genesis Cloud Product Suite
• Enlitic's open opportunity pipeline has grown more than US$60m since its 2024 acquisition of Laitek

Enlitic Inc, a software development company using artificial intelligence to manage medical imaging data, has reported its Quarterly Activity Report and Appendix 4C for the three-month period ended 31 March 2025 (Q1 CY25). The company's unaudited revenue increased to US$0.77m, up 5.8% on the previous quarter (Q4 CY24). Enlitic was named a foundational collaborator in GE HealthCare's new Genesis Cloud Product Suite, with its AI-enabled migration services announced as a key feature. The company's open pipeline opportunity at 31 March 2025 was US$133.4m, up from US$93.3m at the end of 2024, following the successful integration of its acquisition of Laitek in 2024. Enlitic has made significant progress in delivering the expected integration synergies, with US$2m of annualised cost synergies realised to date, and an additional US$1m expected over the remainder of CY2025. The company's cash balance at 31 March 2025 was US$2.78m, with cash outflows in Q1 CY25 including final one-off integration and acquisition costs. Enlitic reaffirms its expectations to reach operational cashflow break-even by the end of CY2025.

Enlitic reaffirms its expectations to reach operational cashflow break-even by the end of CY2025.

Enlitic is actively considering possible options to fund its operations and support its progress to expected operational cashflow break-even by end of CY2025. The company will update the market in due course.